KPV: Mechanism, Research Background, and Laboratory Use

What Is KPV?

KPV is a synthetic tripeptide composed of lysine, proline, and valine (sequence H-Lys-Pro-Val-OH), corresponding to the carboxyl-terminal three amino acids (positions 11-13) of alpha-melanocyte-stimulating hormone (α-MSH). Laboratory research has identified it as one of the smallest fragments of α-MSH that retains anti-inflammatory activity independent of the melanocortin receptors responsible for α-MSH’s pigmentation effects, which is why researchers study KPV separately from full-length α-MSH in inflammation-focused work.

Mechanism of Action

Much of KPV’s studied anti-inflammatory activity centers on inhibition of NF-κB signaling, a transcription factor pathway central to the production of pro-inflammatory cytokines. Research using immobilized and soluble GKPV (a four-residue extension of KPV) found that the peptide significantly inhibited TNF-α-stimulated NF-κB-luciferase activity in cultured cells, with researchers concluding the effect operates through a cell-surface receptor-based mechanism. Separately, KPV has been shown to enter intestinal epithelial cells via the PepT1 oligopeptide transporter, a route used in animal studies to deliver the peptide into gut tissue in a cell-targeted, receptor-independent manner.

Research Background

The bulk of published KPV research comes from gastrointestinal inflammation models. PepT1-mediated uptake of KPV was linked to reduced markers of intestinal inflammation in mouse colitis studies, and later work explored PepT1-targeted nanoparticle delivery systems, including PLGA-KPV formulations and KPV combined with other compounds, to concentrate the peptide in colon tissue under laboratory conditions. Earlier cell-based research also examined KPV’s effects on keratinocyte calcium signaling and cytokine and adhesion-molecule production, extending research interest beyond the gut to skin and general inflammation models. Because KPV shares its parent sequence with the broader α-MSH family, it is frequently discussed alongside other melanocortin-derived peptides in comparative structure-activity research.

Laboratory Handling and Storage

KPV is typically supplied as a lyophilized (freeze-dried) powder and should be stored refrigerated or frozen prior to reconstitution, protected from light and moisture. Once reconstituted with bacteriostatic water, peptide stability is time-limited; the solution should be kept refrigerated, used within the timeframe established by the researcher’s own protocol, and protected from heat, direct light, and vigorous agitation, which can cause peptide aggregation. Standard laboratory peptide-handling practice — sterile technique, minimal freeze-thaw cycling, and accurate labeling with reconstitution date — applies.

Frequently Asked Questions

Disclaimer

This content is provided for laboratory research purposes only and is not intended as guidance for human or animal use. KPV, as sold by Pure Chain Aminos, is a research compound and is not evaluated or approved by the FDA for over-the-counter sale or self-administration. Nothing on this page constitutes medical advice, and no claims are made regarding safety or efficacy in humans or animals outside of a controlled research setting.

More compound research notes

• Selank: Mechanism, Research Background, and Laboratory Use
• Semax: Mechanism, Research Background, and Laboratory Use
• Epitalon: Mechanism, Research Background, and Laboratory Use
• Sermorelin: Mechanism, Research Background, and Laboratory Use
• CJC-1295: Mechanism, Research Background, and Laboratory Use
• Tesamorelin: Mechanism, Research Background, and Laboratory Use
• GHK-Cu: Mechanism, Research Background, and Laboratory Use
• Ipamorelin: Mechanism, Research Background, and Laboratory Use